MTZ Insider Sale: Robert Apple Executes 10b5-1 Plan, Sells 10k Shares
Rhea-AI Filing Summary
Robert E. Apple, Chief Operating Officer of MasTec Inc. (MTZ), reported insider sales executed under a 10b5-1 trading plan on September 18, 2025. The filing shows 9,900 shares sold at a weighted average price of $200.43 and an additional 100 shares sold at $201.06, executed across 47 separate transactions with prices ranging from $200.03 to $201.00. The 10,000 shares sold under the plan represent 5.15% of Mr. Apple’s directly owned MasTec shares. After these transactions the filing reports direct beneficial ownership of 184,349 and 184,249 shares on the respective lines, and 12,068.3991 shares held indirectly via a 401(k) plan. The filing notes a contribution of 85,750 shares to The Apple Family Trust included in the reported holdings.
Positive
- Sales executed under a 10b5-1 plan, indicating the transactions were pre-planned and intended to provide an affirmative defense to insider trading claims
- Detailed disclosure including weighted average price, price range, and an undertaking to provide per-transaction details on request
Negative
- Reduction of direct ownership: 10,000 shares sold represent 5.15% of the reporting person’s directly owned MasTec shares
- Multiple sales executed in 47 transactions may attract investor attention despite being pre-planned
Insights
TL;DR: Routine, pre-planned insider sales under a 10b5-1 program; modest reduction in direct stake, no new concerns disclosed.
The transaction is described as part of an established 10b5-1 plan, executed in multiple tranches at prices between $200.03 and $201.00, yielding a weighted average of $200.43 for the bulk sale. Because the sales were made under an affirmative defense plan, they indicate pre-planned disposition rather than opportunistic trading. The reporting clarifies the composition of holdings, including an 85,750-share transfer to a family trust and 401(k)-plan holdings, which helps reconcile direct versus indirect ownership figures. There are no derivative transactions or amendments disclosed in this filing.
TL;DR: Insiders used a documented Rule 10b5-1 plan to reduce concentration; disclosure is thorough and compliant.
The filing includes explicit statements about the 10b5-1 plan and a weighted-average sale price with an undertaking to provide transaction-level details on request, reflecting transparency. The signature and attestation elements are present. The filing also discloses related-party vehicle holdings (family trust) and 401(k) plan holdings, improving clarity about indirect ownership. From a governance perspective, these elements align with standard disclosure practices and do not indicate undisclosed related-party transactions or material governance issues.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 9,900 | $200.43 | $1.98M |
| Sale | Common Stock | 100 | $201.06 | $20K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Mr. Apple, 75 years old, is systematically reducing his portfolio concentration in MasTec shares through a 10b5-1 plan, which has more than one pricing tranche. These 10,000 shares sold under the plan represent 5.15% of the shares directly owned by Mr. Apple. The price reported in Column 4 is a weighted average price. These shares were sold in 47 separate transactions, with prices ranging from $200.03 to $201.00 for an average weighted sales price of $200.43. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold in each transaction. Includes 85,750 shares of MasTec common stock contributed by the reporting person to The Apple Family Trust of which the reporting person and his wife are trustees and beneficiaries.
FAQ
What insider transactions did Robert E. Apple report for MTZ?
Were the sales by Robert E. Apple planned under a Rule 10b5-1 trading plan?
How much of Mr. Apple’s direct stake did the reported sales represent?
Does the filing disclose indirect holdings or transfers?
What price range did the reported sales occur at?